Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced that Dan Mandoli, a seasoned healthcare executive with more than 30 years of leadership across pharmacy operations and specialty pharmacy services, has joined the Company as Senior Vice President and General Manager, Specialty Pharmacy Services.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608580918/en/
Omnicell Welcomes Dan Mandoli as Senior Vice President and General Manager of Specialty Pharmacy Services
Mr. Mandoli’s deep expertise in leading and driving the growth of specialty pharmacy operations for Fortune 50 and private equity-backed healthcare companies will be instrumental in driving clinical and operational outcomes as the Company seeks to scale and grow its Specialty Pharmacy and 340B businesses.
“Specialty Pharmacy and 340B services are anticipated to be key growth drivers for Omnicell and central to enabling our ability to deliver more value to health systems while improving patient outcomes,” said Nnamdi Njoku, executive vice president and chief operating officer at Omnicell. “Dan brings a strong track record of building and scaling specialty pharmacy businesses, with the operational discipline, market insight, and strategic execution we believe are needed as we strive to accelerate growth in this important market. His leadership is expected to strengthen our ability to expand these capabilities, deepen our value proposition for customers, and advance Omnicell’s long-term growth strategy.”
Most recently, Mr. Mandoli served as Chief Operating Officer at Altruix, where he led operations across specialty pharmacy functions and helped drive significant growth and operational improvements. Prior to that, he was President of Specialty Pharmacy at Elevance Health, where he led strategy, operations, and expansion of a large-scale specialty pharmacy business, including integrating acquisitions and building infrastructure for significant growth. Mr. Mandoli also served as a Senior Advisor for McKinsey & Company, where he was a key part of their pharmacy practice. He has also held senior leadership roles at Express Scripts, including leading Accredo Specialty Pharmacy, one of the largest specialty pharmacy businesses in the United States.
“I find that Specialty Pharmacy is one of the most diverse and complex areas of healthcare. As drug therapies become more targeted, we expect health systems and healthcare entities will need robust solutions to navigate this rapidly growing market,” said Mr. Mandoli. “I’m excited for the opportunity to help shape and lead Omnicell’s global strategy for this growing area of the business.”
Mr. Mandoli holds a Bachelor of Science degree from the University of Michigan. He is actively engaged in expanding educational access for first‑generation college students.
About Omnicell
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260608580918/en/
